The investigators indicated that a small sample size was an obstacle for the evaluation of different effects: age, sex, diabetes, hypertension duration, and antihypertensive treatment. However, it would be useful to present at least the data regarding the use of medications, especially those that block the renin-angiotensin-aldosterone system or sympathetic nervous system. Cardiac extracellular matrix is significantly influenced by these biohumoral systems, so it is quite reasonable to hypothesize that these antihypertensive drugs influence ECV. In the present study, Kuruvilla et al. (1) reported that the non-LVH patients had significantly lower blood pressure levels than the LVH subjects. It is possible that this group had lower ECV because these patients were more often treated with renin-angiotensin-aldosterone system and sympathetic nervous system blockers. 
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